These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37948107)
1. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy. Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107 [TBL] [Abstract][Full Text] [Related]
2. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall. Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841 [TBL] [Abstract][Full Text] [Related]
3. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas. Clark BZ; Beriwal S; Dabbs DJ; Bhargava R Am J Clin Pathol; 2014 Jul; 142(1):64-71. PubMed ID: 24926087 [TBL] [Abstract][Full Text] [Related]
4. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Ramalingam P; Masand RP; Euscher ED; Malpica A Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976 [TBL] [Abstract][Full Text] [Related]
5. Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma. Zhang GN; Susnik B; Paulsen EJ; Lyons LL; Delma KS; Jorda M; Epstein JI; Kryvenko ON Arch Pathol Lab Med; 2024 Oct; 148(10):1110-1118. PubMed ID: 38217332 [TBL] [Abstract][Full Text] [Related]
6. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. So JS; Epstein JI Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157 [TBL] [Abstract][Full Text] [Related]
7. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900 [TBL] [Abstract][Full Text] [Related]
8. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin. Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982 [TBL] [Abstract][Full Text] [Related]
9. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Oliva E; Amin MB; Jimenez R; Young RH Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940 [TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma. Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382 [TBL] [Abstract][Full Text] [Related]
11. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract. Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650 [TBL] [Abstract][Full Text] [Related]
12. Gynecologic Serous Carcinoma: An Immunohistochemical Analysis of Malignant Body Fluid Specimens. Ren S; Klump W Arch Pathol Lab Med; 2019 Jun; 143(6):677-682. PubMed ID: 29688031 [TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
14. Mammaglobin expression in gynecologic adenocarcinomas. Hagemann IS; Pfeifer JD; Cao D Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633 [TBL] [Abstract][Full Text] [Related]
15. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA. Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717 [TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864 [TBL] [Abstract][Full Text] [Related]
17. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ; McCluggage WG Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152 [TBL] [Abstract][Full Text] [Related]
18. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer. Chan E; Garg K; Stohr BA Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185 [TBL] [Abstract][Full Text] [Related]
19. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder. Fatima N; Osunkoya AO Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028 [TBL] [Abstract][Full Text] [Related]
20. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]